Senior Vice President, Hospital Based Specialties
Neonat/Perinatology
Dr. Robin H. Steinhorn, MD
|
|
Give Review
Dr. Robin H. Steinhorn practices Neonat/Perinatology. He attended Washington University School of Medicine in St. Louis. He over the years received 1 awards: "Super Doctor". Robin Steinhorn is also published. He has 99 publications published. The lastest publication: "Contractile properties of intralobar pulmonary arteries and veins in the fetal lamb model of congenital diaphragmatic hernia.'
Publications
- Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension.
- Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.
- Addressing health disparities in rural communities using telehealth.
- Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide.
- Pulmonary hypertension in premature infants. Sharpening the tools of detection.
- Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns.
- Inhaled Nitric Oxide Increases Urinary Nitric Oxide Metabolites and Cyclic Guanosine Monophosphate in Premature Infants: Relationship to Pulmonary Outcome.
- Hydrocortisone normalizes phosphodiesterase-5 activity in pulmonary artery smooth muscle cells from lambs with persistent pulmonary hypertension of the newborn.
- Role of Reactive Oxygen Species in Neonatal Pulmonary Vascular Disease.
- Extracorporeal membrane oxygenation in resource-limited countries*.
- Regulation of Hypoxia-Induced Pulmonary Hypertension by Vascular Smooth Muscle HIF-1alpha.
- Diagnosis and treatment of pulmonary hypertension in infancy.
- Disrupted Pulmonary Artery cGMP Signaling in Mice with Hyperoxia-Induced Pulmonary Hypertension.
- Role of BCL2-associated athanogene 1 in differential sensitivity of human endothelial cells to glucocorticoids.
- Implications of the U.S. Food and Drug Administration Warning against the Use of Sildenafil for the Treatment of Pediatric Pulmonary Hypertension.
- Cyclic stretch induces inducible nitric oxide synthase and soluble guanylate cyclase in pulmonary artery smooth muscle cells.
- Increased p22(phox)/Nox4 Expression Is Involved in Remodeling Through Hydrogen Peroxide Signaling in Experimental Persistent Pulmonary Hypertension of the Newborn.
- Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia.
- Pharmacotherapy for pulmonary hypertension.
- Inhaled Nitric Oxide for Preterm Infants: A Marksman's Approach.
- BRIEF HYPEROXIA INCREASES MITOCHONDRIAL OXIDATION AND INCREASES PDE5 ACTIVITY IN FETAL PULMONARY ARTERY SMOOTH MUSCLE CELLS.
- Hydrocortisone Normalizes Oxygenation and cGMP Regulation in Lambs with Persistent Pulmonary Hypertension of the Newborn.
- Apocynin Improves Oxygenation and Increases eNOS in Persistent Pulmonary Hypertension of the Newborn.
- Fetal Origins of Neonatal Lung Disease: Understanding the Pathogenesis of Bronchopulmonary Dysplasia.
- Pre-term neonate with intestinal failure, feeding issues.
- A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis.
- Pulmonary Hemodynamics and Vascular Reactivity in Asphyxiated Term Lambs Resuscitated with 21% and 100% Oxygen.
- Inhaled nitric oxide and bronchopulmonary dysplasia.
- Every Week Matters.
- Hydrogen Peroxide Regulates Extracellular Superoxide Dismutase Activity and Expression in Neonatal Pulmonary Hypertension.
- Alveolar Capillary Dysplasia.
- Therapeutic approaches using nitric oxide in infants and children.
- SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension.
- Neonatal pulmonary hypertension.
- Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension.
- Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep.
- Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension.
- Medical and financial impact of a neonatal extracorporeal membrane oxygenation referral center in the nitric oxide era.
- Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn.
- Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension.
- Evaluation and management of the cyanotic neonate.
- Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells.
- Pulmonary hemodynamics in neonatal lambs resuscitated with 21%, 50%, and 100% oxygen.
- The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow.
- Use of inhaled nitric oxide in the preterm infant.
- Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension.
- Ovine bronchial-derived relaxing factor: changes with development and hyperoxic ventilation.
- Neonatal extracorporeal life support: impact of new therapies on survival.
- eNOS function is developmentally regulated: uncoupling of eNOS occurs postnatally.
- Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation.
- Selective type 5 phosphodiesterase inhibition alters pulmonary hemodynamics and lung liquid production in near-term fetal lambs.
- Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn.
- The diseases treated with ECMO: focus on PPHN.
- Connecting the cells: vascular differentiation via homeobox genes and extracellular matrix in the distal lung.
- Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase.
- Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow.
- Alterations in TGF-beta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension.
- Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase.
- Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.
- Alterations in nitric oxide production in 8-week-old lambs with increased pulmonary blood flow.
- Type I nitric oxide synthase is decreased in the fetal pulmonary circulation of hypertensive lambs.
- Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.
- Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.
- Sildenafil therapy for bronchopulmonary dysplasia: not quite yet.
- Pilot trial of late booster doses of surfactant for ventilated premature infants.
- Nitric oxide and beyond: new insights and therapies for pulmonary hypertension.
- Inhaled NO in the experimental setting.
- Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn.
- In-house neonatology: what are we waiting for?
- Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.
- Inhaled nitric oxide for premature infants with severe respiratory failure.
- Paracrine role of soluble guanylate cyclase and type III nitric oxide synthase in ovine fetal pulmonary circulation: a double labeling immunohistochemical study.
- Nitric oxide and the developing airway.
- Comparison of pressure-volume-flow relationships in centrifugal and roller pump extracorporeal membrane oxygenation systems for neonates.
- Use of extracorporeal membrane oxygenation in the treatment of respiratory syncytial virus bronchiolitis: the national experience, 1983 to 1988.
- Leukopenia associated with extracorporeal membrane oxygenation in newborn infants.
- Whole blood activated clotting time in infants during extracorporeal membrane oxygenation.
- Determinants of blood product use during extracorporeal membrane oxygenation.
- Inactivation of heparin during extracorporeal circulation in infants.
- Hemolysis during long-term extracorporeal membrane oxygenation.
- Endothelium-dependent relaxations to adenosine in juvenile rabbit pulmonary arteries and veins.
- The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.
- Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment.
- Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension.
- Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios.
- The adventitia may be a barrier specific to nitric oxide in rabbit pulmonary artery.
- Congenital diaphragmatic hernia in Minnesota. Impact of antenatal diagnosis on survival.
- Developmental differences in endothelium-dependent responses in isolated ovine pulmonary arteries and veins.
- Advances in the management of respiratory failure. Nitric oxide.
- Effect of methylene blue on refractory neonatal hypotension.
- The normal pulmonary vascular transition at birth.
- Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia.
- The role of the centrifugal pump in hemolysis during neonatal extracorporeal support.
- Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension.
- Models of persistent pulmonary hypertension of the newborn (PPHN) and the role of cyclic guanosine monophosphate (GMP) in pulmonary vasorelaxation.
- Persistent pulmonary hypertension of the newborn.
- Heterogeneous distribution of soluble guanylate cyclase in the pulmonary vasculature of the fetal lamb.
- Contractile properties of intralobar pulmonary arteries and veins in the fetal lamb model of congenital diaphragmatic hernia.
Schools
Washington Center School of Medicine
Barnes Jewish Hospital
University Of Minnesota
Doctors Specialties
- Neonatal Medicine
- Neonat/Perinatology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Guided Access HMO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Select PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Humana
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
- Western Health Advantage
Awards
- Super Doctor
Education
-
University of Minnesota at Fairview -
Washington University - Barnes-Jewish Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
University of California, Davis Medical Center -
Children's National Medical Center
Helpful Reviews
Similar Doctors
|
|
Nagamani R. Beligere, MB
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdul H. Bhurgri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Radley D. Helin, DO |
|
|
Dr. Ushanalini Vasan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Reda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William R. Hayden, MD |
|
|
Dr. Ameth A. Aguirre, MD |
|
|
Tessy A. Joseph, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Gopal Srinivasan, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prasanna K. Turaka, MD
This Doctor is OpenDoctor Recommended.
|